Providing Market Intelligence for 40 Years

In The News

Why The Twitter-NFL Deal Will Have Fans Cheering

Thursday night games are the ideal platform to experiment with this new form of sports streaming, says Glenn Hower, a research analyst at Parks Associates, a consumer technology market research firm based in Dallas. “Despite the success of the league’s other prime-time offerings with Sunday Night Football and Monday Night Football, Thursday nights haven't resonated the same with viewers,” Hower wrote in an email. With social events and the weekend on the horizon, it is harder to attract viewers for three-and-a-half hours weekly, Packard says. Millennials, especially, aren't likely to sit through a Thursday night game, he says, making Twitter access — which fans can access from most mobile devices at any time — appealing to that demographic.

From the article "Why The Twitter-NFL Deal Will Have Fans Cheering" by Kathleen Burke.

Previously In The News

59% of broadband-enabled UK households now access video content online

The proportion of UK households with broadband connections utilising the service to access online video content has reached 59%, according to new research. Parks Associates relayed their key findin...

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...